BCR-ABL physically interacts with β-catenin and stabilizes and stimulates β-catenin through activation of phosphoinositide 3 kinase (PI3K)/Akt signaling in BP-CML cells. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.